Guided Therapeutics (GTHP) Free Cash Flow (2011 - 2025)
Guided Therapeutics' (GTHP) quarterly Free Cash Flow came in at -$291000.0 in Q4 2025, up 12.35% year-on-year from -$259013.4 in Q4 2024, and down 5.05% quarter-over-quarter from -$277000.0 in Q3 2025.
Guided Therapeutics (GTHP) Free Cash Flow (2011 - 2025) Analysis & Trends
Guided Therapeutics has disclosed Free Cash Flow across 15 years of filings, most recently posting -$291000.0 for Q4 2025.
- Free Cash Flow for Q4 2025 came in at -$291000.0, up 12.35% year-over-year; the trailing twelve-month figure through Dec 2025 was -$1.1 million (up 4.56% YoY), and the FY2025 annual result was -$1.1 million, up 4.38% from the prior year.
- Free Cash Flow came in at -$291000.0 for Q4 2025 at Guided Therapeutics, down from -$277000.0 in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $155000.0 in Q4 2021 to a low of -$744000.0 in Q3 2021.
- The 5-year median for Free Cash Flow is -$334000.0 (2023), against an average of -$352450.0.
- Across the five-year window, Free Cash Flow jumped 146.83% in 2021 and slumped 320.65% in 2022, its largest moves.
- Guided Therapeutics' Free Cash Flow stood at $155000.0 in 2021, then plunged by 320.65% to -$342000.0 in 2022, then rose by 1.75% to -$336000.0 in 2023, then climbed by 1.19% to -$332000.0 in 2024, then grew by 12.35% to -$291000.0 in 2025.
- The last three Free Cash Flow figures came in at -$291000.0 (Q4 2025), -$277000.0 (Q3 2025), and -$169000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 2.30 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 305.56 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 449.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 204.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 245.20 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | -291,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -291,000.00 |
| Dec 31, 2025 | -291,000.00 |
| Sep 30, 2025 | -277,000.00 |
| Sep 30, 2025 | -277,000.00 |
| Jun 30, 2025 | -169,000.00 |
| Jun 30, 2025 | -169,000.00 |
| Mar 31, 2025 | -331,000.00 |
| Mar 31, 2025 | -331,000.00 |
| Dec 31, 2024 | -332,000.00 |
| Dec 31, 2024 | -332,000.00 |
| Sep 30, 2024 | -473,000.00 |
| Sep 30, 2024 | -473,000.00 |
| Jun 30, 2024 | -214,000.00 |
| Jun 30, 2024 | -214,000.00 |
| Mar 31, 2024 | -100,000.00 |
| Mar 31, 2024 | -100,000.00 |
| Dec 31, 2023 | -336,000.00 |
| Dec 31, 2023 | -336,000.00 |
| Sep 30, 2023 | -473,000.00 |
| Sep 30, 2023 | -473,000.00 |